MORPHINE PHEBRA (Phebra Pty Ltd)
Product name
MORPHINE PHEBRA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
127 (255 working days)
Active ingredients
morphine hydrochloride trihydrate
Registration type
New generic medicine
Indication
MORPHINE PHEBRA oral solution is indicated for the short-term management of severe pain for when other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.